7.55
[1]. Besouw M, et al. Cysteamine: an old drug with new potential. Drug Discov Today. 013 Aug;18(15-16):785-9.
[]. Gainer AL, et al. Cysteamine S-phosphate hydrolysis by pure human alkaline phosphatases and by sera from patients with lymphoproliferative disorders. Cancer Res. 198 Sep;(9):3507-9.
[3]. F K Assadi, et al. Effects of pre- and postnatal cysteamine exposure on renal function in the rat. Pediatr Nephrol. 1999 Nov;13(9):81-5.
[]. L A Smolin, et al. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res. 1988 Jun;3(6):616-0.
[5]. L M Bakhitova, et al. [The antimutagenic activity of compounds of modified polyglucin]. Izv Akad Nauk SSSR Biol. 1990 Jul-Aug:():65-8.
H30-H315-H319-H335
P61-P6-P70-P71-P80-P30+P35-P30+P30-P330-P36+P36-P05-P501